Work

Abstract 4208: Azenosertib is a potent and selective WEE1 kinase inhibitor with broad antitumor activity across a range of solid tumors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4208

Authors: Wen Liu, Jianhui Ma, Jiali Li, Daehwan Kim, Sangyub Kim, Alexandra Levy, Kimberly Blackwell, Alejandro Recio-Boiles, Jennifer M. Segar, Shirai Sen, Deborah Doroshow, Danielle Jandial, Olivier Harismendy, Stephan K. Grant, Ahmed Samatar, Mark R. Lackner, Kimberlee M. Fischer

Institutions: Zentalis Pharmaceuticals (United States), University of Arizona Cancer Center, University of Arizona, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409630904

Cites:

Cited by:

Related to: 10